Medical Education – Pannash

Category: Medical Education

This is our archive page

Nonalcoholic steatohepatitis: the role of PPARs (Peroxisome proliferator-activated receptors)

24 February 2021, by Prof Sven Francque

Metabolic drivers of NAFLD

24 February 2021, by G. Bozet, MD

MAFLD, severe COVID-19 and the gut-liver axis

24 February 2021, by G. Bozet, MD

Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease

22 February 2021, by G. Bozet, MD

Sarcopenia: pathophysiological processes in NAFLD

22 February 2021, by G. Bozet, MD

NAFLD and T2D: A bidirectional relationship

19 February 2021, by G. Bozet, MD

Extra-hepatic manifestations of NAFLD

19 February 2021, by G. Bozet, MD

Management of patients with Type 2 Diabetes (T2DM) and Nonalcoholic Fatty Liver Disease (NAFLD)

15 February 2021, by D. Beard

Cost-effectiveness of screening for NAFLD in patients with T2D

15 February 2021, by G. Bozet, MD

NAFLD fibrosis and bone mineral density in diabetic postmenopausal women

15 February 2021, by G. Bozet, MD